MacroGenics | MGNX - Current Liabilities

Stock Price
1.74
Daily Change
0.04 2.35%
Monthly
-4.92%
Yearly
-34.34%
Q1 Forecast
1.65

MacroGenics reported $44.47M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Genmab DKK 629M 127M Jun/2025
Geron USD 87.71M 23.43M Sep/2025
Gilead Sciences USD 11.81B 485M Dec/2025
J&J USD 54.13B 3.26B Dec/2025
Karyopharm Therapeutics USD 87.16M 12.06M Sep/2025
MacroGenics USD 44.47M 5.47M Sep/2025
Merck USD 28.63B 2.59B Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Puma Biotechnology USD 82.73M 3.63M Sep/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Xencor USD 86.48M 9.6M Sep/2025